These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34360656)

  • 1. Recombinant Baculovirus: A Flexible Drug Screening Platform for Chikungunya Virus.
    Varikkodan MM; Chen CC; Wu TY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Bicistronic Baculovirus Expression Vector System to Screen the Compounds That Interfere with the Infection of Chikungunya Virus.
    Kuo SC; Teng CY; Ho YJ; Chen YJ; Wu TY
    Methods Mol Biol; 2016; 1426():263-72. PubMed ID: 27233279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells.
    Metz SW; Geertsema C; Martina BE; Andrade P; Heldens JG; van Oers MM; Goldbach RW; Vlak JM; Pijlman GP
    Virol J; 2011 Jul; 8():353. PubMed ID: 21762510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based analysis of Chikungunya virus E1 protein in membrane fusion.
    Kuo SC; Chen YJ; Wang YM; Tsui PY; Kuo MD; Wu TY; Lo SJ
    J Biomed Sci; 2012 Apr; 19(1):44. PubMed ID: 22520648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based analysis of Chikungunya virus membrane fusion using baculovirus-expression vectors.
    Kuo SC; Chen YJ; Wang YM; Kuo MD; Jinn TR; Chen WS; Chang YC; Tung KL; Wu TY; Lo SJ
    J Virol Methods; 2011 Aug; 175(2):206-15. PubMed ID: 21619896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
    Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
    Tong W; Yin XX; Lee BJ; Li YG
    Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of green fluorescent protein-tagged virus-like particles as a tracer in the early phase of chikungunya infection.
    Tumkosit U; Maeda Y; Kishishita N; Siripanyaphinyo U; Omori H; Chetanachan P; Sittisaman P; Jityam C; Priengprom T; Mizushima H; Wongjaroen P; Mekada E; Tatsumi M; Takeda N; Tanaka A
    Virus Res; 2019 Oct; 272():197732. PubMed ID: 31445103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
    Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.
    Kumar P; Pok KY; Tan LK; Angela C; Leo YS; Ng LC
    J Virol Methods; 2014 Sep; 206():67-75. PubMed ID: 24880071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms.
    Ho YJ; Liu FC; Yeh CT; Yang CM; Lin CC; Lin TY; Hsieh PS; Hu MK; Gong Z; Lu JW
    Antiviral Res; 2018 Nov; 159():134-142. PubMed ID: 30300716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapeutics for chikungunya virus.
    Ghildiyal R; Gabrani R
    Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect Cells.
    Metz SW; Pijlman GP
    Methods Mol Biol; 2016; 1426():297-309. PubMed ID: 27233282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of stearylamine against chikungunya virus.
    Jeengar MK; Kurakula M; Patil P; More A; Sistla R; Parashar D
    Chem Phys Lipids; 2021 Mar; 235():105049. PubMed ID: 33422549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro.
    von Rhein C; Weidner T; Henß L; Martin J; Weber C; Sliva K; Schnierle BS
    Antiviral Res; 2016 Jan; 125():51-7. PubMed ID: 26611396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.